Precision Photobiomodulation

Light. Engineered to Clinical Precision.

Photobiomodulation devices specified to exact wavelength, irradiance, and dose parameters — for practitioners who demand more than consumer wellness.

Certified

CE · FCC

Wavelengths

660 · 850 · 823 nm

Segment

Clinical · Consumer

The Science

Why Photobiomodulation

A mechanistic overview — for informational purposes only. Our devices are general wellness products, not medical devices.

01

Mitochondrial Activation

Specific wavelengths of red and near-infrared light are absorbed by photoreceptors within the mitochondrial electron transport chain, influencing cellular energy production. This photochemical interaction is a well-characterized mechanism studied extensively in peer-reviewed biophysics literature.

02

Cytochrome c Oxidase — The Primary Photoacceptor

Cytochrome c oxidase (Complex IV), a terminal enzyme in the mitochondrial respiratory chain, contains copper and heme centers that exhibit strong absorption bands in the 600–1000 nm range — the optical window most relevant to photobiomodulation research. Wavelength specificity is not incidental; it is a foundational engineering parameter.

03

Wavelength Specificity

Not all wavelengths behave identically in biological tissue. Optical penetration depth, absorption coefficients, and chromophore affinity vary meaningfully across the spectrum. Device specifications — wavelength, irradiance (mW/cm²), dose (J/cm²), and pulse parameters — define the photobiomodulation protocol. Engineering precision matters.

04

Parameter-Defined Dosimetry

Meaningful photobiomodulation research is conducted at defined, reproducible parameters. Our devices are engineered to maintain irradiance consistency, beam uniformity, and emission stability — allowing practitioners and researchers to apply protocols with fidelity to published literature specifications.

The above is provided for informational and educational purposes only. It describes published biophysical mechanisms studied in peer-reviewed literature and does not constitute a claim that our devices diagnose, treat, cure, or prevent any disease or medical condition.

823 nm · Early Access

SpectraLine 823

Featured Device

SpectraLine 823

Our 823 nm flagship operates at a wavelength that appears in independent peer-reviewed literature — including work by Cassano et al. — as a wavelength of interest in transcranial photobiomodulation research. We make no condition claims. What we offer is engineering precision and documented specification.

Key Specifications

Wavelength
823 nm (proprietary)
Treatment Area
Cranial
Availability
Early access — limited
Certifications
CE · FCC

General wellness device. Research referenced independently — not a product efficacy claim.

Compliance

Certifications & Regulatory Standing

These devices are general wellness products and are not FDA 510(k) cleared or FDA approved. They are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Not evaluated by the FDA.

CE

European Conformity

Our devices meet EU health, safety, and environmental requirements. The CE mark indicates conformity with European directives applicable to our device category.

FCC

Federal Communications Commission

FCC certification confirms our devices comply with US electromagnetic compatibility (EMC) standards — addressing radio frequency interference and emissions limits. FCC certification is an equipment authorization, not a medical device clearance.

Important Notice: Zubrio Devices are general wellness products only. They are not medical devices and have not been cleared or approved by the U.S. Food and Drug Administration (FDA). These devices are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Consult a qualified healthcare provider before use.